Thomas A. Hope

16.3k citations

272 papers · 8.8k indexed · 5 hit papers · h-index 50

Impact in

Radiology, Nuclear Medicine and Imaging top 0.1%
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Advanced MRI Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
Pulmonary and Respiratory Medicine top 0.2%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment

Papers in

Radiology, Nuclear Medicine and Imaging 168
- Radiopharmaceutical Chemistry and Applications 97
- Medical Imaging Techniques and Applications 67
- Advanced MRI Techniques and Applications 33
- Radiomics and Machine Learning in Medical Imaging 31
Pulmonary and Respiratory Medicine 137
- Prostate Cancer Treatment and Research 104
- Prostate Cancer Diagnosis and Treatment 42

Co-authors: Michael D. Hope Marcus T. Alley Wolfgang P. Fendler Jérémie Calais Ken Herrmann Karen Ordovás Peder E. Z. Larson Peter R. Carroll
Journals: Journal of Nuclear Medicine (49 papers)Journal of Clinical Oncology (32 papers)Abdominal Radiology (14 papers)Radiology (9 papers)European Journal of Nuclear Medicine and Molecular Imaging (8 papers)
Partner nations: United States Germany Canada

In The Last Decade

Thomas A. Hope

258 papers receiving 8.7k citations

Hit Papers

5 papers align trajectories log scale

Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2) 2023 · 127 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 European Urology
2021 European Journal of Nuclear Medicine and Molecular Imaging
2019 Pancreas
2017 Journal of Nuclear Medicine
2017 European Journal of Nuclear Medicine and Molecular Imaging

Peers

Countries citing papers authored by Thomas A. Hope

Since Specialization

Citations

This map shows the geographic impact of Thomas A. Hope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Hope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Hope more than expected).

Fields of papers citing papers by Thomas A. Hope

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Hope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Hope. The network helps show where Thomas A. Hope may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas A. Hope, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas A. Hope Line = papers co-authored together Thomas A. Hope links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pre- or post-chemotherapy: effect on PSMA uptake EJNMMI Research ·G Chassoux, Invonne Suryana, Г.В. Андреенко, Fei Jiang, Roxanna Juarez, Ivan de Kouchkovsky, Robert R. Flavell, Rahul Aggarwal, Thomas A. Hope	2025	1
2	Impact of Posttreatment SPECT/CT on Patient Management During¹⁷⁷Lu-PSMA-617 Radiopharmaceutical Therapy Journal of Nuclear Medicine ·G Chassoux, 高橋弘喜, Invonne Suryana, Fei Jiang, U ZINGONI, Rahul Aggarwal, Roxanna Juarez, Robert R. Flavell, Thomas A. Hope	2024	10
3	Efficacy and Toxicity of [¹⁷⁷Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data Journal of Nuclear Medicine ·Vishnu Murthy, Andrew F. Voter, Kathleen Nguyen, Martin Allen-Auerbach, Lucia Chen, João Pedro Moreira Gonçalves, Elisa M. Ledet, Danielle Strunk, Invonne Suryana, Courtney Lawhn-Heath, А В Дудин, Michael A. Carducci, Martin G. Pomper, Channing J. Paller, Johannes Czernin, Lilja B. Sólnes, Thomas A. Hope, Oliver Sartor, Jérémie Calais, Andrei Gafita	2024	4
4	Efficacy and toxicity of [¹⁷⁷Lu]Lu-PSMA-617 for metastatic castration-resistant prostate cancer in a real-world setting: Results from the U.S. Expanded Access Program and comparisons with phase 3 VISION data. Journal of Clinical Oncology ·Jérémie Calais, Vishnu Murthy, Andrew F. Voter, Kathleen Nguyen, Martin Allen-Auerbach, João Pedro Moreira Gonçalves, Elisa M. Ledet, Sankha Banerje, Invonne Suryana, Courtney Lawhn-Heath, Michael A. Carducci, Martin G. Pomper, Channing J. Paller, Johannes Czernin, Lilja B. Sólnes, Thomas A. Hope, Oliver Sartor, Andrei Gafita	2024	1
5	Mechanical processing of wet stored fly ash for use as a cement component in concrete Magazine of Concrete Research ·Michael J. McCarthy, Thomas A. Hope, László Csetényi	2024	0
6	Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to ¹⁷⁷Lu-PSMA-617: A Retrospective Multicenter Cohort Study JCO Precision Oncology ·Arkadii I Lipkin, George Mo, Invonne Suryana, Laura Graham, Roman Gulati, Colin C. Pritchard, Michael C. Haffner, Todd Yezefski, Jessica E. Hawley, Heather H. Cheng, Evan Y. Yu, Petros Grivas, Bruce Montgomery, Peter S. Nelson, Delphine L. Chen, Thomas A. Hope, Amir Iravani, Michael T. Schweizer	2024	7
7	Real-World Experience with¹⁷⁷Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval Journal of Nuclear Medicine ·Invonne Suryana, G Chassoux, Fei Jiang, Sarasa T. Kim, U ZINGONI, Devin Patrick Kelly, Roxanna Juarez, Courtney Lawhn-Heath, J. G. Thaulow, Ivan de Kouchkovsky, Thomas A. Hope	2024	8
8	Mixed Supervision of Histopathology Improves Prostate Cancer Classification From MRI IEEE Transactions on Medical Imaging ·Emad Basheir I. Elmagboul, Antonio C. Westphalen, D. E. Oliver, Jeffry Simko, Hao G. Nguyen, Thomas A. Hope, Peder E. Z. Larson, Kirti Magudia	2024	0
9	Assessment of response to PRRT including anatomical and molecular imaging as well as novel biomarkers Journal of Neuroendocrinology ·Grace Kong, Paula Barros, Cherie Chiang, Ken Herrmann, Thomas A. Hope, Michael Michael	2024	2
10	Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel Abdominal Radiology ·Sonia Lee, Zahra Kassam, Akshay Baheti, Thomas A. Hope, Kevin J. Chang, Elena Korngold, Melissa W. Taggart, Natally Horvat	2023	28
11	PET/MRI in colorectal and anal cancers: an update Abdominal Radiology ·Vetri Sudar Jayaprakasam, Semra İnce, Garima Suman, Pankaj Nepal, Thomas A. Hope, Raj Mohan Paspulati, Tyler J. Fraum	2023	7
12	The PRIMARY Score: Using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer diagnosis. Journal of Nuclear Medicine ·Louise Emmett, Nathan Papa, James P Buteau, Bao Ho, Victor Liu, Matthew J. Roberts, James Thompson, Daniel Moon, Gemma Sheehan‐Dare, Omar Alghazo, Shikha Agrawal, Declan G. Murphy, Phillip D. Stricker, Thomas A. Hope, Michael S. Hofman	2022	68
13	Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET Cancers ·Bataulatundu Lakshminarayanan, Osama Mohamad, Katie Lichter, Thomas A. Hope	2022	8
14	Prostate-specific Membrane Antigen PET in Prostate Cancer Radiology ·Courtney Lawhn-Heath, Ali Salavati, Spencer C. Behr, Steven P. Rowe, Jérémie Calais, Wolfgang P. Fendler, Тарас Пащенко, Louise Emmett, Michael S. Hofman, Thomas A. Hope	2021	52
15	Understanding and Visualizing Generalization in UNets Emad Basheir I. Elmagboul, Wolfgang Zillich, Thomas A. Hope, Peder E. Z. Larson	2021	1
16	Assessment and Comparison of ¹⁸F-Fluorocholine PET and ^99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis Journal of Nuclear Medicine ·Binti Md Nazri Haslinda, Isabel Elaine Allen, Emily K. Bergsland, Insoo Suh, Thomas A. Hope	2021	22
17	Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial European Urology Open Science ·Justin Ferdinandus, Wolfgang P. Fendler, Jérémie Calais, Hicran Yıldız Şimşek, Robert R. Flavell, Ashley Mishoe, Akiko Ota, Hao G. Nguyen, Robert E. Reiter, Matthew B. Rettig, J Gartmann, 實濱口, Eric J. Small, Roger Slavik, Peter R. Carroll, Karin A. Herrmann, Johannes Czernin, Thomas A. Hope	2020	2
18	Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer Clinical Cancer Research ·Wolfgang P. Fendler, Manuel Weber, Amir Iravani, Michael S. Hofman, Jérémie Calais, Johannes Czernin, Harun Ilhan, Fred Saad, Eric J. Small, Matthew R. Smith, Antanas Burbo, Thomas A. Hope, Isabel Rauscher, Anil Londhe, Angela Lopez‐Gitlitz, Shinta Cheng, Tobias Maurer, Ken Herrmann, Matthias Eiber, Boris Hadaschik	2019	183
19	Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy Molecular Pharmaceutics ·Sinan Wang, Charles Blaha, Raquel Alves dos Santos, Tony L. Huynh, Thomas R. Hayes, Denis Beckford-Vera, Joseph Blecha, Julie L. MacIssac, Tatiana Añazco-Loayza, Thomas A. Hope, David R. Raleigh, David M. Wilson, Michael J. Evans, Henry F. VanBrocklin, Tomoko Ozawa, Robert R. Flavell	2019	40
20	Tumor cell heterogeneity and resistance; report from the 2018 Coffey‐Holden Prostate Cancer Academy Meeting The Prostate ·Andrea K. Miyahira, Robert B. Den, Maria I. Carlo, Renée de Leeuw, Thomas A. Hope, Fatima Karzai, Rana R. McKay, Simpa S. Salami, Jonathan W. Simons, Kenneth J. Pienta, Howard R. Soule	2018	12

About Thomas A. Hope

Thomas A. Hope is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Neurology and Hepatology, having authored 272 papers that have together received 8.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (104 papers), Radiopharmaceutical Chemistry and Applications (97 papers), Medical Imaging Techniques and Applications (67 papers), Neuroendocrine Tumor Research Advances (44 papers), Prostate Cancer Diagnosis and Treatment (42 papers), Advanced MRI Techniques and Applications (33 papers), Radiomics and Machine Learning in Medical Imaging (31 papers) and Lung Cancer Research Studies (31 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (4.6k citations), Pulmonary and Respiratory Medicine (4.5k citations), Neurology (1.1k citations), Oncology (1.8k citations) and Hepatology (515 citations). Thomas A. Hope has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Michael D. Hope, Marcus T. Alley, Wolfgang P. Fendler, Jérémie Calais, Ken Herrmann, Karen Ordovás, Peder E. Z. Larson, Peter R. Carroll, Frederik L. Giesel and Charles B. Higgins. Their work appears in journals such as Journal of Nuclear Medicine, Journal of Clinical Oncology, Abdominal Radiology, Radiology and European Journal of Nuclear Medicine and Molecular Imaging.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact